A new clue to predicting pre-eclampsia

May 9, 2012, University of Sydney
(L-R) Dr David Eviston, new mother Kristy Herd Hayley Herd and Professor Ralph Nanan.

(Medical Xpress) -- An indication of whether a mother will develop pre-eclampsia, the most common and severe pregnancy-related disease, has been identified by a University of Sydney study.

As reported in The Sydney Morning Herald today the findings, published in the latest edition of the Journal of Reproductive Immunology, could allow the early detection of pre-eclampsia, which currently cannot be diagnosed by symptoms before the disease occurs.

The research also suggests the womb may have a lasting impact on a child's immune system.

"Pre-eclampsia affects an estimated 5000 to 10,000 women in Australia every year," said Professor Ralph Nanan, senior author of the study, from Sydney Medical School Nepean.

It develops in mothers out of the blue, usually in the last three months of pregnancy, causing , kidney and and severe blood changes. Delivering the baby as soon as possible is the only way to stop it."

In pre-eclampsia the mother's immune system appears to attack the fetus.

"Our study looked at the thymus of the fetus, a structure which sits behind the baby's and is known as the 'cradle' of an important set of called thymus-derived lymphocytes or ," said Professor Nanan.

No previous study has looked at the effect of the disease on the fetal .

"Surprisingly we found the thymus of babies whose mother developed pre-eclampsia was significantly smaller than in babies of healthy pregnant women."

What further surprised the researchers was that these changes were obvious in mid-pregnancy, long before the mother developed any signs of pre-eclampsia.

"This is a very interesting finding as the thymus plays a central role in shaping the child's immune system and protecting it against the development of allergies, autoimmune disease and cancers later in life," Professor Nanan said.

The group is now conducting a prospective study with over 1200 pregnant women to confirm the findings with the long-term prospect of developing a test for pre-eclampsia. It is also conducting studies which aim to describe the short and long-term effects that early thymus changes have on the child's immune system and on the development of immune diseases.

The study was conducted by David Eviston, Ann Quinton and a team of researchers from Sydney Medical School Nepean.

Explore further: Stroke risk in pregnant women 2.4 times higher

Related Stories

Stroke risk in pregnant women 2.4 times higher

July 8, 2011
High blood pressure during pregnancy is a leading cause of maternal and fetal mortality worldwide.

New study suggests dietary supplement can protect against pre-eclampsia

May 20, 2011
A dietary supplement containing an amino acid and antioxidant vitamins, given to pregnant women at high risk of pre-eclampsia, can reduce the occurrence of the disease, finds a study published in the British Medical Journal ...

Test for pre-eclampsia developed

May 4, 2011
(Medical Xpress) -- Scientists at King’s have pioneered a new method of identifying early in pregnancy which healthy first-time mothers are at risk of developing pre-eclampsia, a potentially life threatening condition ...

Recommended for you

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.